As an experienced CDMO, our capabilities enable us to successfully partner with pharmaceutical and biotech companies in developing medicines from molecule development to commercialization.
Our teams of scientists have a broad range of chemistry expertise as well as specialized skills which enable us to support our clients throughout the development and manufacturing journey.
Our regulatory-compliant facilities and equipment further enable us to be flexible, efficient, and cost-effective. Our dedicated state-of-the-art laboratories are equipped with automated jacketed reactors (100-5000 mL) can generate 100-200 grams of the final product with desired critical quality attributes (CQAs). We have manufacturing capacity for API scale-up, ranging from 50-150 kg and non-GMP to cGMP production units equipped with 60 kg bulk production of semi-synthetic products.